ibuprofen and seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide

ibuprofen has been researched along with seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gui, Y; Hollenberg, M; Loutzenhiser, K; Loutzenhiser, R; Trottier, G; Wang, X1

Other Studies

1 other study(ies) available for ibuprofen and seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide

ArticleYear
PAR-2 elicits afferent arteriolar vasodilation by NO-dependent and NO-independent actions.
    American journal of physiology. Renal physiology, 2002, Volume: 282, Issue:5

    Topics: Acetylcholine; Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arterioles; Enzyme Inhibitors; Hydronephrosis; Ibuprofen; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Oligopeptides; Potassium Chloride; Rats; Rats, Sprague-Dawley; Receptor, PAR-2; Receptors, Thrombin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vasodilation

2002